Under construction – not a live service
Sign in
Not yet taking people in BelgiumNo phase

Tracking leg muscle changes after brain injury or stroke over time

Tracks leg muscle stiffness and structure in adults after a brain injury.

Plain-language title generated from the registry record
Registry title: Natural Evolution of Muscle Structure and Stiffness Following Brain Lesion

Key facts

Where
Brussels, BelgiumSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with weakness on one side of the body after a first stroke or traumatic brain injury within the last month. It follows how leg muscles change over time.

Age
18 to 80 years
Sex
Women and men can join.
Disease stage
Weakness on one side of the body (hemiparesis) after a first stroke or traumatic brain injury, less than 1 month ago.

Main reasons for not taking part

  • Weakness in both sides of the body
  • Major problems with thinking that limit the tests
  • Another nerve or bone problem that affects the weak limb
  • Underlying nerve and muscle disease, such as myasthenia gravis or amyotrophic lateral sclerosis
  • Cannot have an MRI scan

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06718608, who can take part

Where in Belgium

  • Cliniques universitaires Saint-LucBrussels, BelgiumContact: Marine Devis, MDNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Trial code
NCT06718608
Record updated
5 December 2024
Original description
We propose to carry out a single center, prospective, interventional trial to assess the natural evolution of lower limb muscle structure and muscle stiffness of hemiparetic patients following brain damage. Patients will be assessed two weeks, one month, three months and six months after their brain lesion.Read full original descriptionShow less

Natural Evolution of Muscle Structure and Stiffness Following Brain Lesion

We propose to carry out a single center, prospective, interventional trial to assess the natural evolution of lower limb muscle structure and muscle stiffness of hemiparetic patients following brain damage. Patients will be assessed two weeks, one month, three months and six months after their brain lesion.

Secondary objectives:

To compare the muscle stiffness and structure of patients who will develop muscle overactivity to patients who won't develop muscle overactivity.

To compare the muscle structure and muscle stiffness of the spastic lower limb muscles and the non-spastic lower limb muscles in the affected limb.

To compare the muscle structure and muscle stiffness of the affected and the non-affected lower limb.

To study the relationship between impairment and function by applying a comprehensive and original method to assess all aspects from muscle structure and mechanics to patient's functional capacities.

Inclusion: Female or male ≥ 18 years and ≤ 80 years at screening; Hemiparesis secondary to a first stroke or traumatic brain injury; < 1 month post-stroke/brain injury Subjects must meet all of the inclusion criteria in order to be eligible to participate in the study.

Exclusion: Underlying neuromuscular disease (e.g. myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis); Bilateral limb paresis; Major cognitive impairments limiting the functional evaluation; Neurological or orthopedic affection interfering with the paretic limbs function; Contraindication to perform MRI Subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.

ClinicalTrials.gov NCT06718608